Alkermes (ALKS) Gross Profit Growth (3y) (2013 - 2026)
Alkermes (ALKS) Gross Profit Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | 6.23% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 3.42% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -0.01% |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | 8.70% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -3.26% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 28.48% |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | 8.60% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Alkermes | 8.11 Bn | 7.46 Bn | 397.90 Mn | -10.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -10.45% |
| Mar 31, 2026 | 13.03% |
| Dec 31, 2025 | 10.50% |
| Sep 30, 2025 | 109.72% |
| Jun 30, 2025 | 101.53% |
| Mar 31, 2025 | 4.83% |
| Dec 31, 2024 | 10.75% |
| Sep 30, 2024 | 8.81% |
| Jun 30, 2024 | 10.45% |
| Mar 31, 2024 | 11.51% |
| Dec 31, 2023 | 9.04% |
| Sep 30, 2023 | 12.92% |
| Jun 30, 2023 | 39.88% |
| Mar 31, 2023 | 4.86% |
| Dec 31, 2022 | 100.37% |
| Sep 30, 2022 | -30.51% |
| Jun 30, 2022 | -30.77% |
| Mar 31, 2022 | 7.92% |
| Dec 31, 2021 | 593.48% |
| Sep 30, 2021 | 5.33% |